Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

NCT03158129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Stage I Lung Non-Small Cell Cancer AJCC v7
Stage IA Lung Non-Small Cell Carcinoma AJCC v7
Stage IB Lung Non-Small Cell Carcinoma AJCC v7
Stage II Lung Non-Small Cell Cancer AJCC v7
Stage IIA Lung Non-Small Cell Carcinoma AJCC v7
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
Stage IIIA Lung Non-Small Cell Cancer AJCC v7

Interventions

DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Docetaxel
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab
DRUG: Pemetrexed

Sponsor

M.D. Anderson Cancer Center